Immunovant, Inc.
Hedge Funds Holdings
Last updated:
Immunovant, Inc.‘s stocks are currently a part of 80 hedge funds’ portfolios, which represents 12.77% of the total amount of its stocks outstanding. This makes up a total of 16.41M shares of Immunovant, Inc.. Compared to the previous quarter, the number fell by -70.93% or -40.03M shares fewer. As for the holding position changes, 38.75% (31) of current hedge fund investors increased the number of shares held, 26.25% (21) of current holders sold a part of the shares held, and 3.75% (3) closed the holdings completely. 16 hedge funds are new holders of Immunovant, Inc. stock in Q1 2023, it is 20% of total holders.
Hedge funds holding Immunovant (Q4 2019 – Q1 2023)
| Q4 2019 | 24 |
|---|---|
| Q1 2020 | 40 |
| Q2 2020 | 87 |
| Q3 2020 | 115 |
| Q4 2020 | 146 |
| Q1 2021 | 119 |
| Q2 2021 | 110 |
| Q3 2021 | 118 |
| Q4 2021 | 118 |
| Q1 2022 | 112 |
| Q2 2022 | 89 |
| Q3 2022 | 109 |
| Q4 2022 | 131 |
| Q1 2023 | 80 |
Hedge funds changes in Immunovant positions (Q4 2019 – Q1 2023)
| Q4 2019 | 24 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2020 | 21 | 8 | 7 | 5 | -1 |
| Q2 2020 | 47 | 29 | 11 | 0 | 0 |
| Q3 2020 | 39 | 53 | 20 | 11 | -8 |
| Q4 2020 | 43 | 54 | 39 | 11 | -1 |
| Q1 2021 | 28 | 50 | 30 | 54 | -43 |
| Q2 2021 | 21 | 45 | 31 | 30 | -17 |
| Q3 2021 | 26 | 41 | 39 | 18 | -6 |
| Q4 2021 | 22 | 39 | 44 | 20 | -7 |
| Q1 2022 | 13 | 38 | 43 | 19 | -1 |
| Q2 2022 | 9 | 31 | 30 | 27 | -8 |
| Q3 2022 | 24 | 33 | 33 | 4 | 15 |
| Q4 2022 | 39 | 54 | 26 | 18 | -6 |
| Q1 2023 | 16 | 31 | 21 | 3 | 9 |
Hedge funds changes in Immunovant stock options (Q4 2019 – Q1 2023)
| Q4 2019 | 0 | 0 |
|---|---|---|
| Q1 2020 | 412,000 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 15,450,000 | 6,892,000 |
| Q2 2021 | 56,423,000 | 8,844,000 |
| Q3 2021 | 47,876,000 | 3,475,000 |
| Q4 2021 | 22,938,000 | 1,118,000 |
| Q1 2022 | 6,871,000 | 532,000 |
| Q2 2022 | 2,511,000 | 629,000 |
| Q3 2022 | 3,177,000 | 614,000 |
| Q4 2022 | 8,867,250 | 246,300 |
| Q1 2023 | 1,723,317,000 | 794,200,000 |